Ruotao Xiao1,2, Chuxiao Xu1,2, Wei He1,2, Lei Liu1, Hongxian Zhang1, Cheng Liu2, Lulin Ma3. 1. Peking University Health Science Centre, 100191, Beijing, People's Republic of China. 2. Department of Urology, Peking University Third Hospital, No.49 North Garden Road, Haidian District, 100191, Beijing, People's Republic of China. 3. Department of Urology, Peking University Third Hospital, No.49 North Garden Road, Haidian District, 100191, Beijing, People's Republic of China. malulin@bjmu.edu.cn.
Abstract
BACKGROUND : This study aimed to determine the prognostic value of preoperative blood parameters in renal cell carcinoma (RCC) and tumour thrombus (TT) patients that were surgically treated. METHOD: We retrospectively analysed clinicopathological data and blood parameters of 146 RCC and TT patients that were surgically treated. Univariate or multivariate Cox regression analyses were performed to determine the risk factors associated with progression-free survival (PFS) and overall survival (OS). Kaplan-Meier analysis and logistic regression were performed to study the risk factors. Receiver operating characteristic curves were applied to test improvements in the predictive accuracy of the established prognosis score. RESULTS: On univariate and multivariate analysis, anaemia (HR 2.873, P = 0.008) and lymph node metastasis (HR 4.811, P = 0.015) were independent prognostic factors linked to OS. Besides, thrombocytosis (HR 2.324, P = 0.011), histologic subtype (HR 2.835, P = 0.004), nuclear grade (HR 2.069, P = 0.033), and lymph node metastasis (HR 5.739, P = 0.001) were independent prognostic factors associated with PFS. Kaplan-Meier curves revealed that patients with anaemia exhibited worse OS than those without it (P = 0.0033). Likewise, patients with thrombocytosis showed worse PFS than those without it (P < 0.0001). Adding the anaemia and thrombocytosis to the SSIGN score improved its predictive accuracy related to OS and PFS. Preoperative anaemia was linked to more symptom at presentation (OR 3.348, P = 0.006), longer surgical time (OR 1.005, P = 0.001), more blood loss (OR 1.000, P = 0.018), more transfusion (OR 2.734, P = 0.004), higher thrombus level (OR 4.750, P = 0.004) and higher nuclear grade (OR 3.449, P = 0.001) while thrombocytosis was associated with more symptom at presentation (OR 7.784, P = 0.007). CONCLUSIONS: Preoperative anaemia and thrombocytosis were adverse prognostic factors in non-metastatic RCC patients with TT. Also, both preoperative anaemia and thrombocytosis can be clinically used for risk stratification of non-metastatic RCC and TT patients.
BACKGROUND : This study aimed to determine the prognostic value of preoperative blood parameters in renal cell carcinoma (RCC) and tumour thrombus (TT) patients that were surgically treated. METHOD: We retrospectively analysed clinicopathological data and blood parameters of 146 RCC and TTpatients that were surgically treated. Univariate or multivariate Cox regression analyses were performed to determine the risk factors associated with progression-free survival (PFS) and overall survival (OS). Kaplan-Meier analysis and logistic regression were performed to study the risk factors. Receiver operating characteristic curves were applied to test improvements in the predictive accuracy of the established prognosis score. RESULTS: On univariate and multivariate analysis, anaemia (HR 2.873, P = 0.008) and lymph node metastasis (HR 4.811, P = 0.015) were independent prognostic factors linked to OS. Besides, thrombocytosis (HR 2.324, P = 0.011), histologic subtype (HR 2.835, P = 0.004), nuclear grade (HR 2.069, P = 0.033), and lymph node metastasis (HR 5.739, P = 0.001) were independent prognostic factors associated with PFS. Kaplan-Meier curves revealed that patients with anaemia exhibited worse OS than those without it (P = 0.0033). Likewise, patients with thrombocytosis showed worse PFS than those without it (P < 0.0001). Adding the anaemia and thrombocytosis to the SSIGN score improved its predictive accuracy related to OS and PFS. Preoperative anaemia was linked to more symptom at presentation (OR 3.348, P = 0.006), longer surgical time (OR 1.005, P = 0.001), more blood loss (OR 1.000, P = 0.018), more transfusion (OR 2.734, P = 0.004), higher thrombus level (OR 4.750, P = 0.004) and higher nuclear grade (OR 3.449, P = 0.001) while thrombocytosis was associated with more symptom at presentation (OR 7.784, P = 0.007). CONCLUSIONS: Preoperative anaemia and thrombocytosis were adverse prognostic factors in non-metastatic RCCpatients with TT. Also, both preoperative anaemia and thrombocytosis can be clinically used for risk stratification of non-metastatic RCC and TTpatients.
Authors: Jiwei Huang; Adam S Feldman; Liang Dong; Kristine Cornejo; Qiang Liu; Douglas M Dahl; Shulin Wu; Michael L Blute; Yiran Huang; Chin-Lee Wu Journal: Clin Genitourin Cancer Date: 2015-05-04 Impact factor: 2.872
Authors: Ryan Hutchinson; Charles Rew; Gong Chen; Solomon Woldu; Laura-Maria Krabbe; Matthew Meissner; Kunj Sheth; Nirmish Singla; Nabeel Shakir; Viraj A Master; Jose A Karam; Surena F Matin; Leonardo D Borregales; Christopher Wood; Timothy Masterson; R Houston Thompson; Stephen A Boorjian; Bradley C Leibovich; E Jason Abel; Aditya Bagrodia; Vitaly Margulis Journal: Urology Date: 2018-02-27 Impact factor: 2.649
Authors: Georg C Hutterer; Daniel Krieger; Edvin Mrsic; Kristof Pohlmann; Angelika Bezan; Tatjana Stojakovic; Karl Pummer; Richard Zigeuner; Martin Pichler Journal: Anticancer Res Date: 2015-06 Impact factor: 2.480
Authors: Charles C Peyton; E Jason Abel; Juan Chipollini; David C Boulware; Mounsif Azizi; Jose A Karam; Vitaly Margulis; Viraj A Master; Surena F Matin; Jay D Raman; Wade J Sexton; Christopher G Wood; Philippe E Spiess Journal: Eur Urol Focus Date: 2018-09-08